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Melanizationa b s t r a c t
Innate immune mechanisms are well conserved throughout evolution, and many theoretical concepts,
molecular pathways and gene networks are applicable to invertebrate model organisms as much as ver-
tebrate ones. Drosophila immunity research beneﬁts from an easily manipulated genome, a fantastic
international resource of transgenic tools and over a quarter century of accumulated techniques and
approaches to study innate immunity. Here we present a short collection of ways to challenge the fruit
ﬂy immune system with various pathogens and parasites, as well as read-outs to assess its functions,
including cellular and humoral immune responses. Our review covers techniques for assessing the kinet-
ics and efﬁciency of immune responses quantitatively and qualitatively, such as survival analysis, bacte-
rial persistence, antimicrobial peptide gene expression, phagocytosis and melanisation assays. Finally, we
offer a toolkit of Drosophila strains available to the research community for current and future research.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The Drosophila immune system has been the focus of intense
studies and is now one of the best-characterized among Metazo-
ans. Studies show that insect immune systems are complex and
share many characteristics of the vertebrate innate immune
system. The nature of the Drosophila immune response is depen-
dent on the mode of infection, the type of pathogen and route of
challenge, the tissue(s) affected, developmental stage, genotype
and many other physiological parameters including the presence
of symbiotic bacteria. Since immune reactions are not as tightly
regulated as developmental processes, speciﬁc attention to all
these physiological parameters is essential before reaching any
conclusion. Physiological processes have a multitude of ways of
interfering with host survival to infection; as an immune response
requires the rapid reallocation of resources it easily enters in com-
petition with other vital processes [1,2]. As a consequence many
immune and non-immune factors contribute to survival. Generally,
any mutants that affect the general ﬁtness of ﬂies in some way or
other tend to exhibit higher susceptibility to infection. For in-
stance, stress and repair programs have recently entered centre
stage in host defence as exempliﬁed by accumulating work on
the gut [3,4].This also raises another point to consider when assessing
immunity: the immune response is compartmentalized or tissue-
speciﬁc. We traditionally distinguish the systemic immune
response on one hand, which takes place in the body cavity and in-
volves hemolymph, hemocytes and the fat body, and local immune
responses on the other hand, that take place in barrier epithelia
such as the gut and the tracheae [5]. Humoral and tissue-speciﬁc
immunity is complemented by powerful intracellular defence
mechanisms such as RNAi, which is an essential defence against
virus.
In the wild, Drosophila is infected at various stage of its life cycle
by viruses, parasites (nematodes, parasitoid wasps), protozoans
(for example trypanosomes [6]), fungi (yeast, ﬁlamentous and
Microsporidians) and bacteria. Each of these microbes triggers a
rather distinct set of overlapping immune pathways. Flies are also
infected by two vertically transmitted endosymbionts, Wolbachia
and Spiroplasma. While there is no evidence that these highly co-
evolved symbionts trigger or are affected by the immune system,
both classes of endosymbionts can promote symbiont-mediated
defence; Wolbachia protects ﬂies against viruses while Spiroplasma
exerts protection against wasps and nematodes [7,8]. The presence
of Wolbachia which is found in many lab stocks should be taken
into consideration.
The immune response can be analysed after challenge or under
basal conditions. The basal immune response is affected by envi-
ronmental microbes associated with the ﬂies such as bacteria
found in the gut or ingested from the substratum. In these cases,
germ-free (axenic) or gnotobiotic (i.e. with deﬁned microbiota)
ﬂy culture allows deﬁning the contribution of these microbes to
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ditionally divided into a cellular response that involves hemocytes
and the humoral response that includes and melanisation and the
production of antimicrobial peptides and other effectors. Studies
have shown that all Drosophila stages can mount effective immune
responses, although some of them are stage-speciﬁc (for example,
the exclusively larval lamellocyte production during encapsulation
of parasitoid wasp eggs). Embryos and pupae are interesting mod-
els to study wound healing reactions, hemocyte motility and
phagocytosis of apoptotic cells (that will not be described here).
Humoral and cellular immune responses are usually studied in
both larvae and adults. Since the maturation of immune respon-
siveness is strongly dependent on ecdysone [9,10], immune path-
ways in the adult stage are less affected by developmental
timing. It should be noted that AntiMicrobial Peptides (AMPs)
(and many immune genes) show very high levels of inducibility
(equivalent to heat-shock genes). Their expression proﬁles are
inﬂuenced by multiple parameters and not surprisingly, these
genes are picked up in many microarray studies. It is also impor-
tant to determine whether the observed immune activation has a
direct or an indirect cause. For instance, most mutations disrupting
the gut compartmentalization lead to higher antimicrobial peptide
gene expression in this tissue [11]. This is similar to the observa-
tion that many mutations can cause melanotic tumours (cellular
like immune response) in a number of indirect ways [12].
Many mutations affect the immune response and in some cases,
the differences observed can be down to the genetic background
for all the reasons stated above (effect of background on survival
for example is illustrated in Fig. 2A). To study subtle immune phe-
notypes, it is therefore recommended to compare mutants and
wild-type in several different background contexts. For instance,
use two wild-type stocks such as CantonS and OregonR and different
combinations of mutants (for example mutation over a deﬁciency,
mutant and RNAi).
After raising these points of caution, we describe below some of
the methods used in our lab and others to study the immune re-
sponse to microbes and parasites, with an emphasis on antimicro-
bial defence mechanisms.
2. Commonly used pathogens and culture conditions
Various types of microbes can be used to challenge the Drosoph-
ila immune system. Rather than using mammalian pathogens, the
organisms of choice are entomopathogenic microorganisms, which
naturally infect wild Drosophila populations, and are particularly
informative as both parties have evolved attack and survival mech-
anisms. Among these, genetically tractable organisms in particular
have the added value of allowing parallel screening of pathogen
virulence genes and host resistance/tolerance genes. Of note,
strains from the same bacterial species group can behave differ-
ently as virulence factors differ from strain to strain.
2.1. Bacteria
Among the large variety of commonly used bacteria, not all are
naturally infecting insects. Below we describe two commonly used
Gram-negative entomopathogenic bacteria, with further infectious
lab strains listed in Table 1. Where available, bacteria carrying ﬂuo-
rescent markers or resistance genes can be used for ease of quan-
tiﬁcation or re-isolation from the host.
2.1.1. Gram-negative bacteria
Pectobacterium (old name Erwinia) carotovora carotovora is a
Gram-negative bacterium that causes soft rot in plants and is nat-
urally transmitted by insects. The strain Ecc15 is particularlyattractive as it is genetically tractable to some extent, stable,
can naturally infect Drosophila, and triggers a very strong immune
response while exhibiting a mild lethality in wild-type ﬂies. The
use of this strain has been instrumental in studying the systemic
immune response as well as the local immune response in
trachea or gut and. Ecc15 is grown as a shaking culture in LB
medium at 29 C and can be reliably identiﬁed by its ‘‘rotten
potato’’ smell. To infect ﬂies, an overnight culture of 50–100 ml
is pelleted by centrifugation (15 min at 3200g) and adjusted to
OD600 = 200. Running plates of Ecc15 can be kept for a month at
4 C to start liquid cultures. The Ecc15 wild-type strain carries
genomic rifampicin resistance, and a GFP-transformed strain
(spectinomycin-selectable) is available for ﬂuorescent tracing of
bacteria. Note that the GFP ﬂuorescence contributes slightly to
absorbance at 600 nm and pellet density needs to be adjusted
accordingly [13,14].
Another naturally occurring lethal Gram-negative entomo-
pathogen is Pseudomonas entomophila, isolated from a ﬂy in Guade-
loupe. P. entomophila is cultured like Ecc15 but is more sensitive to
pelleting, because compacted or air-exposed bacteria tend to lyse.
This bacterium is genetically unstable and avirulent GacA-like mu-
tants are observed at high frequency. Verifying strains can be done
by growing on milk-agar plates to test the proteolytic activity
(wildtype but not GacA) [15–17]. A variety of useful P. entomophila
mutants have been isolated, including the non-virulent GacA
strain, or protease and toxin mutants.
Alternative Gram-negative bacteria are Providencia [18], Serratia
marcescens (notably the strain Sm DB11-40, [19]), or Pseudomonas
aeruginosa [20,21], which can be found associated with ﬂies in
the wild. Laboratory strains of Escherichia coli, although not associ-
ated with wild ﬂies, have also been used to probe the immune sys-
tem, notably the Imd pathway which is activated by DAP-type
PGN.
2.1.2. Gram-positive bacteria
Gram-positive bacteria can be divided into two types based on
their peptidoglycans. Lysine-type peptidoglycan bacteria are
strong inducers of the Toll pathway while DAP-type peptidoglycan
Gram-positive bacteria including the Bacillus and Listeria genus
activate both the Toll and Imd pathways.
Most Lysine-type Gram-positive bacteria are pathogenic to ﬂies
upon injection, with the notable exception of Micrococcus luteus
that can be used as a non-lethal inducer of the Toll pathway.
Enterococcus faecalis and Staphylococcus aureus have been used to
probe the Toll pathway in survival experiments, and occasionally
Aerococcus viridans has been used to stimulate a Toll-dependent
immune response. S. aureus is especially interesting to probe the
role of phagocytosis and melanization [22,23,131]. Among
DAP-type Gram-positive bacteria, Listeria monocytogenes, Listeria
innocua, Bacillus megaterium and Bacillus subtilis are currently being
used (for example [24]).
Mycobacterium marinum has been used as a Drosophila model
for tuberculosis and exhibits the slow killing and wasting charac-
teristics of the disease in humans [25,26].
2.2. Fungi
Beauveria bassiana and Metarhizium anisopliae area naturally
occurring insect pathogens which infect by breaching the cuticle
during sporulation, thanks to a battery of proteo- and lipolytic en-
zymes. B. bassiana is cultured on malt agar plates at 18–29 C, in
the dark. Higher temperatures result in faster growth rates but
may favour contaminating bacteria; to prevent this, plates can be
sealed with paraﬁlm. Usually cultures take 1 month to sporulation,
which can be induced by switching to 29 C. It is important to keep
Table 1
Commonly used pathogens.
Bacterium Gram Culture conditions Dose, route and temperature of infection
Escherichia coli Negative, DAP-type LB, 37 C OD600 = 400 (S), OD600 = 200 (O), 29 C
Erwinia carotovora carotovora 15 Negative, DAP-type LB, 29 C OD600 = 200 (S), OD600 = 100 (O), 25–29 C
Pseudomonas entomophila Negative, DAP-type LB, 29 C OD600 = 200 (O), 29 C
Enterobacter cloacae b12 Negative, DAP-type LB, 37 C OD600 = 10 (S), 22–29 C
Salmonella typhimurium Negative, DAP-type LB, 37 C OD600 = 0.1–10 (S), 22–29 C
Listeria monocytogenes Positive, DAP-type BHI, 37 C OD600 = 0.01–200 (S), 22–29 C
Bacillus subtilis Positive, DAP-type LB, 37 C OD600 = 5–20 (S), 22–29 C
Micrococcus luteus Positive, Lys-type LB, 29 C OD600 = 200 (S), 29 C
Staphylococcus aureus Positive, Lys-type LB, 37 C OD600 = 0.5–200 (S), 22–29 C
Staphylococcus saprophyticus Positive, Lys-type LB, 37 C OD600 = 5 (S), 22–29 C
Enterococcus faecalis Positive, Lys-type LB, 37 C OD600 = 0.01–20 (S), 22–29 C
Fungus, yeast
Candida albicans YPG broth, 29 C OD600 = 200 (S), 22–29 C
Beauveria bassiana 802 Malt agar, 25–29 C Roll ﬂies in sporulating dish, 29 C
Metarhizium anisopliase KVL 131 Malt agar, 25–29 C Roll ﬂies in sporulating dish, 29 C
Aspergillus fumigatus Spore suspension (S), 29 C
Note that lower doses should be used when microbes are micro-injected. Infectious doses are indicated as a range; lower concentrations are useful for sublethal challenges.
Abbreviations: S, systemic infection; O, oral infection; YPG, yeast peptone glucose; LB, Luria Bertani; BHI, Brain–Heart-Infusion.
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form. To propagate cultures, ﬂip sporulating plates to new mal
agar. Running plates can be kept up to 1.5 months at 18 C or until
dark spots appear on the fungal lawn.
Other fungi need to be injected to trigger an immune response.
Candida albicans is a yeast-like fungus that triggers a strong activa-
tion of the Toll pathway. As this fungus exhibits little proteolytic
activity, it will elicit a GNPB3-Toll immune response, which has
been well characterized [27]. Injection of spores of Aspergillus
fumigatus likewise triggers a strong systemic antifungal immune
response.
Recently, the immune response to microsporidian species has
been addressed [28].2.3. Parasites
In the wild, young Drosophila larvae are often infested by a vari-
ety of parasitoid wasps [29]. Some are speciﬁc to Drosophila mela-
nogaster (for example Leptopilina boulardi) while others are
generalists (for example Leptopilina heterotoma, Asobara tabida),
and parasitoid strains differ in their virulence. The more virulent
wasps can be propagated in wild-type strains of Drosophila, while
less virulent wasps, such as A. tabida, are better cultivated in
PPO1, PPO2 double mutants or Drosophila subobscura. Parasitoid
wasps will emerge 7–10 days later than ﬂies. The adult parasitoid
wasps can be kept on sucrose/agar or honey.
For more information, consult: http://www.jove.com/video/
3347/an-introduction-to-parasitic-wasps-drosophila-antiparasite-
immune.
Few papers have analyzed the ﬂy response to protozoans (Cri-
thidia, [30]) and nematodes. For nematodes, recently updated
methods are available [31–33].3. Infectious routes
Drosophila are naturally exposed to pathogens while foraging on
decaying fruit, so the most common route of access is by oral infec-
tion to the digestive system or by contact with the tracheal system.
However, wild insects also sustain injuries to the cuticle and
subsequent introduction of microorganisms into the hemocoel.
Sporulating fungi likewise are able to breach the cuticle and extend
hyphae into the sterile body cavity. The latter two modes ofinfection are most easily reproduced in the lab by pricking with a
pathogen-contaminated needle.
3.1. Systemic infection
To introduce pathogens into the body cavity, anaesthetized
adult ﬂies are pricked into the thorax with a thin metal needle
dipped in a concentrated bacterial pellet or a suspension of fun-
gal spores (for illustration, see [34]). Pricking into the thorax
rather than the abdomen reduces the risk of damaging the intes-
tines, which can easily result in secondary bacteraemia from
microbiota. Individuals normally recover quickly after pricking,
and the wound site usually displays melanisation within a few
hours. To avoid scoring lethally injured individuals, dead ﬂies
should be counted at 2 h after pricking and removed from fur-
ther analysis.
While needle pricking is a quick and efﬁcient way to deliver a
shot of infectious agent, a more precise dosage may be required
for certain experiments. For this kind of experiment, it may be use-
ful to microinject a deﬁned volume (nanoliters) of bacterial pellet
using a pulled glass capillary mounted on a Nanoject™ apparatus
(for illustrations, see [34]). Capillaries however tend to cause larger
wounds, a stronger melanisation reaction and longer recovery
times than needles. Alternative methods have been described such
as eye injection, genitalia infection [35,132] and placing ﬂies with
cut-off legs on contaminated medium. Food vials with freshly
injured ﬂies can be kept sideways to prevent weakened individuals
from sticking to the medium.
Larval systemic infection is performed with a ﬁner tungsten
needle into the posterior lateral side of larvae immobilized on a
pre-chilled rubber pad. Larvae can be deposited straight into the
bacterial pellet for ease of manipulation. Injured larvae are placed
on sealed 5 cm petri dishes containing apple juice agar or normal
ﬂy medium.
After infection, ﬂies or larvae are transferred to the temperature
most adapted to optimal pathogen growth (see Table 1).
For infection with fungi, spores can be directly injected as de-
scribed for bacteria, but for entomopathogenic fungi, the method
of choice is to place CO2-anaestethized ﬂies directly on the sporu-
lating fungal lawn and to shake the culture plates until ﬂies are
uniformly covered in spores (for illustrations, see [34]). Flies will
become gradually infected as spores germinate and breach the
cuticle [36].
C. Neyen et al. /Methods 68 (2014) 116–128 1193.2. Oral infection
For oral infection, 2–4 day old adults are dehydrated/starved for
2–3 h in empty vials at 29 C to ensure synchronous feeding of all
individuals when ﬂipped into infection vials. An infection vial con-
sists of standard medium (but without live yeast) completely cov-
ered by a Whatman paper disk (Fig. 1A and [15]). The disk is
soaked in control solution (10% sucrose) or bacterial pellet mixed
with control solution. 120–150 ll are sufﬁcient to soak a 22 mm
diameter disk. Starved ﬂies are ﬂipped into the infection vials
and kept at optimal temperature for pathogen growth. Experimen-
tal evidence suggests that bacteria on the ﬁlter disk do not remain
viable beyond a couple of hours, therefore it is possible to ﬂip in-
fected ﬂies onto fresh medium after an initial infection phase
(24 h for example). Other methods include placing ﬂies on paper
towels soaked with bacteria. In this case, fresh bacterial or sucrose
solution should be frequently added to avoid dehydration (result-
ing in continuous infection) [19]. The method of infection (for
example with or without prior starvation, continuous or one-shot
delivery of bacteria) can have a strong inﬂuence on the outcome
of the infection.
For natural infection of larvae, individuals are incubated in con-
centrated solution of bacteria alone or mixed with crushed banana
[13]. To prevent larvae from crawling out of the infectious food,
transfer them to Eppendorf tubes and plug with a foam stopper.
After 30 min, larvae are removed from the mix and transferred to
normal food vials. Larvae continue to be infected in the vials.
Washing larvae allows stopping the ingestion of bacteria and
monitoring persistence. Tracheal infections of larvae are usually
carried out at a lower temperature to allow sufﬁcient time, before
pupariation, for the development GFP ﬂuorescence from reporterFig. 1. Oral infection methods and read-outs. (A) Preparation of ﬂy vials for oral infectio
with 120–150 ll bacterial solution shortly before infection. (B) Fluorescent monitoring of
were fed a GFP-tagged non-lethal Gram- bacterium, Erwinia carotovora carotovora 15 (Ecc1
tracked under a ﬂuorescence binocular as bright ﬂuorescence within the abdominal ar
blockage occurring during infection. Bottom panels: reporter ﬂies carrying Dpt-mCherry,
monitored at 20 h for systemic induction of diptericin (mCherry) under a ﬂuorescence bin
of mCherry [108]. (C) Kinetics for disappearance of bacteria and appearance of immunegenes. Monitoring the percentage of infected trachea by expression
of Drs-GFP is described in Section 4.1.4.3.3. Injection of immune elicitors
Injection of microbes leads to complex immune responses be-
cause they involve growth of the microbe within the host. Injection
of dead bacteria allows circumventing this problem. To activate a
speciﬁc branch of the immune response pure elicitors can be used
such as TCT (ligand for the Imd activating receptors PGRP-LE and
PGRP-LCx/a), DAP-type peptidoglycan (to activate PGRP-LC and
PGRP-LE and to a lesser extent PGRP-SA), Lysine-type peptidogly-
can (PGRP-SA), b-glucan (GNBP3), proteases (to activate the
psh-Toll pathway). Note that pure LPS has no effect on antimicro-
bial peptide gene expression but most commercially available LPS
preparations (Sigma for example) do show activation of Imd
because of trace contaminations by peptidoglycan [37,38]. Pure
products can be purchased from InvivoGen or obtained from
laboratories specialising in bacterial cell wall biochemistry.3.4. Wasp parasitisation
For wasp infection, 20–30 second instar wild-type larvae are co-
housed with 3–4 A. tabida females for 2 h. Parasitized larvae are
kept at 625 C until capsule dissection 4–6 days post-infection.
Lamellocyte differentiation can be visualized by phalloidin staining
of hemolymph preparations or with the use of lamellocyte
markers.n. Whatman ﬁlters (can be sterilized) are layered on top of the medium and soaked
bacterial presence and systemic immune response to oral infection. Top panels: ﬂies
5), or sucrose as control, for indicated time points. The presence of GFP-Ecc15 can be
ea. After 6–8 h, the ﬂuorescence disappears due to gut emptying and food uptake
with or without the PGRP-LB mutation, were subjected to the same diet as in a, but
ocular. The fat body of reporter ﬂies, deﬁcient for PGRP-LB, shows a strong induction
response signal, derived from observations as in B.
Fig. 2. Survival and colony counting. (A) Survival of different wild-type strains to systemic infection with Ecc15 (needle pricking, OD600 = 200, at 29 C). Data represent
cumulated counts (oreR, 211 males; CanS, 553 males; w, 266 males) from 2 different experimenters over a span of 4 years. Median survival: oreR 82 h, CanS 142 h, w 168 h. p
values by log-rank test: oreR vs w p < 0.0001; CanS vs w p = 0.0068. p values by Gehan–Breslow–Wilcoxon test: oreR vs w p < 0.0001; CanS vs w p < 0.0001. The increased
survival of the w strain is reﬂected by a stronger Imd response in these ﬂies. (B) Serial dilutions of ﬂy lysates 24 h after infection. Lines 2 and 3 are immuno-compromised and
show enhanced bacterial growth. (C) ImageJ processing of colonies for automated counting. Images need to be taken with high gamma distortion to optimize sharpness of
colonies. Using FIJI/ImageJ [109], convert to an 8bit image, use the commands ‘‘convert to mask’’ then ‘‘watershed’’ then ‘‘analyse particles’’ to obtain colony counts per image.
Note that the watershed process is only able to some extent to separate colonies that have grown into each other (compare top panel to bottom panel). Grow plates at room
temperature instead of 29 C overnight to prevent colony overlap and to optimize the accuracy of automated counting.
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The Drosophila gut lumen is an environment with relatively low
bacterial diversity and numbers (1–30 species, 103–105 CFU/ﬂy).
While the number of bacteria is quite consistent at the third larval
stage, numbers in adults are extremely variable and the existence
of a stable population of dividing bacteria residing in the gut has
not yet been formally demonstrated [39–41]. Bacteria found in
the Drosophila gut are also found in the substratum, suggesting
constant contamination through feeding. Germ-free ﬂies are easily
generated by dechorionating embryos with chlorox and then sur-
face-sterilizing them in 70% ethanol. Sterile dechorionated em-
bryos are transferred to autoclaved ﬂy medium in sterile vials,
taking special care not to transfer larvae along with the embryos
as their gut contents would re-infect the entire population. Notethat germ-free ﬂies will not spontaneously acquire microbiota
and need to be placed in the presence of bacteria (derived from
other ﬂies or from a culture) to re-acquire their microbiota. Recent
papers have added to our understanding of the nature of Drosophila
microbiota. Note that germ-free conditions do not only change the
gut microbial environment but also the substratum.
The Drosophila symbiont Wolbachia can be removed by treating
ﬂies with tetracycline as described in [7].4. Methods for scoring the response to infection
It is becoming increasingly appreciated that immunity to infec-
tion does not simply imply getting rid of the causative agent.
Homeostasis also requires tissue regeneration and wound healing,
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resources which may have implications on fertility and life span;
or possible epigenetic changes which poise the individual against
subsequent infections. Below we outline the most commonly used
methods and tools to assess outcome of infection, in order to
inform such post-infection concepts as resistance, tolerance, resil-
ience, hormesis etc.
4.1. Commonly used ﬂy stocks
All ﬂies listed in this publication are publically available
through the Bloomington stock centre or will be made available
shortly.
4.1.1. Immune deﬁciency mutants
Table 2 lists commonly used immune deﬁciency mutants. For
the Imd pathway, imd1 and RelE20 show a complete loss of antimi-
crobial peptide induction and adults usually die from Gram-
negative infection within 24–48 h. For RelE20, it is advisable to
use the cleaned-up background without the ebony marker
[42,43]. Note that the E20 deletion affects another gene. The Imd1
(hypomorph) mutation and null mutations in dTAK1 and PGRP-LC
are slightly weaker than null mutations of other members of the
pathway (dredd, Ikkß, IKKc, Tab, dFADD, Imd). The background of
the stock inﬂuences its overall resistance (see also Fig. 2A) and
many mutations are done in the y,w background which shows
higher immunoreactivity than for example oreR or CanS. The best
way to activate the Imd pathway is to over-express Imd, PGRP-LC,
PGRP-LE or the truncated, transcriptionally active form of Relish
(Rel68) [44–47].
The Toll pathway has many other non-immune functions and
Toll deﬁcient mutants show some zygotic lethality during larval
stage with few escapers [48]. Mutations that can be used include
spzrm7 (perfectly viable); a combination of Toll alleles (Tlr632/Tl1-
RXA), pell74 (a strong hypomorph), and MyD88. The pathway can
be activated by over-expression of many genes (for example spz,
Pelle, Toll. . .) or using a gain-of-function mutation in Tl (Tl10b or
uas-Tl10b) or cactus-deﬁcient ﬂies. Mutations in serine proteases
or pattern-recognition receptors upstream of Toll tend to block
one of the extracellular branches upstream of SPE and Spz.
Decent RNAi lines for in vivo targeting of the Toll and Imd path-
ways are also available (for example FADD-IR, Pelle-IR) [49,50].
To target melanisation, several mutants lacking hemolymph PO
have been described. The most historic is Black cells, a gain-of func-
tion mutation in PPO1 that affects both PPO1 and PPPO2 proteins
([51], Neyen, unpublished observations). More recently, a double
PPO1, PPO2 mutant was generated which shows complete absence
of PO activity in the hemolymph [131].
Mutants that lack all hemocytes have been described (domino,
L(3)hem) but they exhibit many other defects as they lack all dip-
loid cells [52]. Viable ﬂies lacking all or most plasmatocytes are
called phagoless and can be generated by crossing a hemocyte
gal4 driver (Hml-Gal4 or spn-Gal4) to either uas-Bax or both uas-
hid and uas-rpr [53,54].
4.1.2. Methods for identifying novel immune genes based on large scale
screens and expression proﬁling
A powerful large-scale tool to identify genes involved in im-
mune activation or regulation is RNA interference (RNAi), either
in cell-based screens or in a slightly more laborious in vivo setting
[55]. While the patchy efﬁciency of ﬁrst generation RNAis
relegated in vivo screens to ﬁshing expeditions, improved sec-
ond-generation RNAi libraries promise optimized throughput in
RNAi-based screens. S2-based RNAi screens have successfully
identiﬁed novel Toll, Imd and JNK pathway components [56–59],
determinants of intracellular pathogen resistance [60] orphagocytic receptors on hemocytes [61,62], and in vivo RNAi
screens have contributed to our understanding of Drosophila
hemocyte development or response to intestinal infection [63,64].
While unbiased reverse genetic screens can be useful to identify
novel gene functions, a targeted approach based on contextual
gene expression may speed up the process considerably. Micro-
arrays represent a rich source of co-regulated genes in different tis-
sues and infectious conditions, and have been comprehensively
reviewed in [65]. The Pathogen Associated Drosophila MicroArray
(PADMA) database (www.padmadatabase.org) regroups accessible
microarray data sets from a variety of immune challenges [66]. A
list of annotated immune genes involved in the Drosophila immune
response as well as a collection of microarrays giving transcrip-
tional proﬁles upon systemic infection, intestinal infection and tra-
cheal infection are available here: http://lemaitrelab.epﬂ.ch/
resources.
RNAseq datasets represent another avenue to identify novel im-
mune-regulated genes through their association with known im-
mune genes in co-regulated clusters [67]. Finally, the Drosophila
Genetic Reference Panel (DGRP) represents a unique asset for pop-
ulation genomics and genome-wide association studies (GWAS)
based on 168 fully sequenced strains that can be subjected to
any number of infectious challenges [68]. Importantly, polymor-
phisms associated with changes in immune function coming from
this kind of screen will bring to light regulatory, intergenic regions
in addition to protein-encoding genes. A ﬁrst hit with an immune
function identiﬁed through this GWAS approach is pastrel, a gene
that confers allele-speciﬁc resistance to common Drosophila
viruses [69].
4.1.3. Methods to generate immune deﬁcient cells, tissues or organisms
Many of the classical mutants described in Section 4.1.1 stem
from historical EMS (ethyl methanesulfonate) screens. Forward ge-
netic screening based on alkylating agents has the beneﬁt of unbi-
ased targeting of the genome, and can give rise to a variety of
mutations from nulls to temperature-sensitive hypomorphs. While
mapping EMS mutations can be time-consuming, novel sequenc-
ing-based methods have greatly improved efﬁciency of mapping
[70,71]. Transposon mutagenesis, albeit suffering from insertion
bias [72], allows for easy retrieval of positional information, and
forms the basis for a downstream toolkit of genetic applications
including imprecise excision knock-out, Gal4-UAS overexpression
of ﬂanking genes, or element replacement by targeting vectors,
to name but a few [73–77]. Extensive libraries of P-element-based
transposon insertions are available through stock centers, along
with deletion and duplication lines [78–81]. Finally, targeted gene
knock-out using optimized targeting plasmids in combination with
CRISPR will greatly accelerate full KO coverage of the ﬂy genome
[82].
To address the cell- or tissue-autonomous function of a gene, or
to circumvent lethality issues, clonal analysis is a method of choice
[83]. While genetic mosaics have been mostly used to delineate
neural development pathways, twin-spot and MARCM techniques
can be easily adapted to immune tissues [84–87]. Additionally,
RNA interference has been widely used to reduce gene expression
in a tissue- and time-controlled manner, preventing developmen-
tal effects. For more extensive methodology on genome engineer-
ing, RNAi screens or navigating large-scale data sets to retrieve
gene expression information, the reader is referred to the relevant
contributions to this issue.
4.1.4. Flies carrying reporter constructs
Large-scale screens require easily scorable read-outs that can be
quickly visually inspected. For antimicrobial peptide induction,
ﬂuorescent and enzymatic reporter genes are available for both






Antimicrobial peptide gene reporters
P{Dpt-lacZ, ry+};;ry [110] Carries Diptericin-lacZ insertion on X. Transgene containing 2.2 kb of the Dpt promoter; provides an
accurate read-out of the Imd pathway in most tissues
y,w, P{Dpt-lacZ, ry+}, P{Drs-GFP, w+} [5,111] Carries Diptericin-lacZ and Drs-GFP on X. Note that the GFP is secreted (fused after position 59 of the
Drosomycin CDS)
w, P{Drs-lacZ, w+} [111] Carries Drs-lacZ on X. The Drs-lacZ reporter gene is very strong and shows a signiﬁcant basal activity
in larvae
w; P{Dpt-GFP, w+}D3-2,{Dpt-GFP, w+}3-4 [14] Carries two recombined copies on each third chromosome (four insertions in total). Useful for
analysis of Dpt expression in barrier epithelia
yw;;P{dpt::cherry-C1, w+} [53] Good reporter of Dpt expression
w;; P{Dipt-Dpt-HA, w+} [93] Carries Dpt promoter followed by Dpt CDS and tag. Reporter of Dpt expression that allows following
the expression of the antibacterial peptide
Mutations affecting the Imd pathway
Dipt-lacZ I; b, pr, imd1 [112] Homozygous viable mutation on the second chromosome. imd1 is a strong hypomorph found in the
old BL1046 Bc stock. Susceptible to Gram-negative bacteria
y,w,DreddB118 [43] Null mutation in Dredd. Homozygous viable.
y1,w⁄,Tak12 BL26272 [113] Null mutation in dTAK1. Homozygous viable. Susceptible to Gram-negative bacteria
w;; PGRP-LCE12 (see also
BL36323)
[45] Null mutation in the Imd pathway receptor. See also w⁄; PGRP-LCD5
RelishE20, e+ [42,43] A deletion of relish which also affects a nearby gene. The ebony marker of the original stock
(Hultmark lab) was removed by recombination with the Oregon stock. Susceptible to Gram-
negative bacterial infection
y1,w67c23,PGRP-LE112 BL33055 [114] A mutation affecting the pattern-recognition receptor PGRP-LE that regulates the Imd pathway in
the midgut and in the fat body
y1,w67c23,PGRP-LE112,PGRP-LCE12 [115] A stock that lacks the two receptors of the Imd pathway
dFADD-IR NIG 12297R-1 [50] This RNAi reduces Imd pathway activity
w; UASimd,hspgal4/TM6C [50] The P[uas-imd, w+] insertion [44] was recombined with hs-gal4 allowing activation of the Imd
pathway
w;; PGRP-LBD1 [108] A deletion of the negative regulator of the Imd pathway PGRP-LB. PGRP-LB scavenges
peptidoglycan, thereby determining the level of Imd pathway activation.
y1,w67c23; P{EPgy2}pirkEY00723 BL15039 [116–118] A null mutation the negative regulator Pirk
Mutations affecting the Toll pathway
spzrm7/TM6C (see also spz2 ca1/TM1) (see also
BL3115)
Spzrm7 is a genetically null, homozygous viable mutation in spz generated by EMS. Several markers
of the original stock (M317 Tübingen stock center) including ebony were removed by
recombination
Tl1-RXA, e/TM6C (or any other null allele
of Toll)
Null mutation in Toll. The TM3SerSB balancer of the original stock was replaced by TM6C
Tlr632, ca/TM6C (Tlr632 was renamed Tlr3) BL3238 A thermosensitive mutation in Toll. Tl deﬁcient mutant larvae and adults can be produced by
keeping Tlr632/Tl1-RXA late embryos and young larvae at permissive temperature (18–20 C) and
transferring them to restrictive temperature at the pupal stage
mwh1 e1 Tl8/T(1;3)OR60/TM3, Sb1 Ser1 BL30914 Oregon 60 is a dominant male lethal mutation. Tl8 (Tl10b) is a dominant female sterile mutation
(embryos are ventralized). In this stock all the males are Tl8/TM3SerSb. To obtain Tl8 ﬂies, cross these
males with wild-type females. Tl8 constitutively activates the Toll pathway inducing a strong
expression of the Drosomycin reporter gene and melanotic tumors
P{uas-Tl10b} Generated by Jean-Marc Reichhart
y,w, DD1,PGRP-SAseml [119] Homozygous viable mutation in PGRP-SA. Generated by EMS mutagenesis
w;; ModSP1 [24] This null mutation in ModSP blocks the Pattern-recognition branch upstream of the Toll pathway
w; P[w+, uas-MODSP} [24] Over-expression of UAS-ModSP activates the Toll pathway
Pelle-IR NIG 5974R-1 [49] This RNAi stock from the NIG (Mishima) can be used to reduce Toll pathway activity by targeting
the kinase Pelle
RelE20, spzrm7 [120] A double mutant lacking Toll and Imd pathway activity (no inducible expression of antimicrobial
peptide gene expression)
Mutations affecting melanization and clotting pathways
P{Dpt-lacZ, ry+} I; Bc/Bc BL1036 [51,112] Dominant mutation affecting an unknown gene located on the second chromosome. Bc/+ larvae
show 50% proPo activity and melanised crystal cells. Bc homozygous larvae show no PO-activity
and melanized crystal cells. This Bc stock derived from the old BL1046 Bc imd1 stock. Another Bc
stock is Bc1 fj1 wt1 (BL1036)
w; spn27A25A/Cyo-actin-GFP [120] Null mutation by P element excision of serpin 27A. Spn27A mutants show decreased viability at the
pupal stage. Spn27A larvae and adults show an excessive melanisation reaction after injury
w; Spn28D1/CyOGFP II [121] Deletion of serpin 28D. Spn28D mutants show lethality at the pupal stage and excessive
melanization
w; PPO1[w+] [131] Deletion of PPO1 by homologous recombination (insertion of w+)
w; PPO2[w] [131] Deletion of PPO2 by imprecise excision
w;PPO1,PPO2[w+] [131] While mutations in PPO1 reduce melanization, no hemolymphatic melanization is found in PPO1,
PPO2 double mutants
Hayan1 [97] Null mutation by P element excision of Hayan which encodes the terminal serine protease of the
melanisation cascade. Hayan mutants show a systemic wound response defect and a complete
absence of hemolymph PO activity
w1118; PBac{WH, #3}Hmlf03374 BL18646 [122] A null mutation in hemolectin. Shows some defect in clotting
w1118; fonD24A/CyO, P{ActGFP}JMR1 BL4344 [123] A null mutation in Fondue. Shows some defect in clotting





Gal4 Drivers (fat body and hemocytes)
w; P{yolk-Gal4, w+)/TM3Ser The yolk-Gal4 driver strongly expresses Gal4 in the adult fat body of females (and also follicle cells
of the ovary). This insertion lowers the viability of ﬂies and as a consequence, yolk-Gal4 stocks are
usually kept at 23 C. The strength of the driver may be inﬂuenced by nutritional state
w; P{GawB}c564 BL6982 The c564 driver strongly expresses Gal4 in the adult fat body (and in parts of the gut and
hemocytes)
P{ppl-GAL4.P} [124] The ppl-Gal4 driver strongly expresses Gal4 in the larval and adult fat body (and also in the gut). It is
weaker than c564 at the adult stage
Hemocyte drivers and markers
w1118; P{Hml-GAL4.D}2, P{UAS-
2xEGFP}AH2
BL30140 [53,54] This GAL4 line expresses in all the plasmatocytes. Note that this line is deleted for NimC1 gene
[133]. It can be used in combination with uas-Bax or uas-Hid, uas-Rpr to eliminate plasmatocytes
hemese-Gal4 [125] This GAL4 line expresses brightly in most (80%) of hemocytes
w; Srp(hemo)Gal4,UASGFP [126] This GAL4 line expresses dimly in all hemocytes and hemocyte progenitor cells
w; pxn-gal4 8.9,uas-GFP [127] This GAL4 line expresses brightly in all plasmatocytes
Lz-Gal4;UAS GFP [128] This GAL4 line expresses brightly in all crystal cells
w, Eater-Gal4, UAS-2xEYFP; BcF6-CFP;
MSNF9-mCherry
[129] This line labels all three hemocytes types; Eater-Gal4 drives eYFP expression in plasmatocytes,
crystal cells express CFP and lamellocytes express mCherry
w; 2x[HmlD-dsRed.nuc]/SM6a [130] These lines carry two independent insertions on Chr II or ChIII and label all plasmatocyte nuclei
dsRed+w;; 2x[HmlD-dsRed.nuc]/TM6c
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antimicrobial peptide genes. GFP-reporters tend to be slower and
not very quantitative compared to lacZ reporters which are very
sensitive but stable. Diptericin (Dpt-lacZ, Dpt-GFP, Dpt-mCherry) is
the best read-out for the Imd pathway. Toll pathway activity can
be monitored by the expression of DIM2 or Drosomycin. One should
however bear in mind that Drosomycin induction receives a signif-
icant input from the Imd pathway (especially at early time points)
and is regulated by the Imd pathway in tracheae. Lines carrying
both the Dpt-lacZ and Drs-GFP on the X allow assessing both path-
ways in a same ﬂy.
A new set of reporter genes have been generated that allow
identifying each hemocyte population. Some of these reporter
genes mark only differentiated cells while other mark all the lin-
eages (see Table 2).
4.2. Survival
Survival to infection is the most holistic approach to assessing
defects in immune response. As Drosophilists are not restricted
by ethical considerations, sufﬁciently large numbers of individuals
can and should be scored (typically at least 3 biological repeats
with cohorts of 30 individuals per genotype and pathogen). Tech-
nical issues to consider: if using females, the medium will quickly
be worked by hatching larvae and may require more frequent ﬂip-
ping in early stages of an experiment. If using males, the issue of
offspring does not arise, but vials containing only males tend to
grow sticky with bacteria quicker, and need ﬂipping every 2–
3 days throughout the experiment. Usually infections are done on
CO2 anaesthetized ﬂies at room temperature using a cold light.
Flies that die within 6 h are removed from the count and are con-
sidered dead by injury.
Depending on the question addressed, infections can be done
with lethal or sublethal doses (Table 1). A lethal dose typically
should kill all wild-type ﬂies at a constant rate, while a sublethal
dose will kill only a fraction of individuals, with the recovered
fraction surviving at a plateau before dying from old age or im-
muno-pathological collateral damage. Statistical considerations:
if using a lethal dose, usually the assumption of proportional haz-
ards is true, i.e. death rate for one genotype is constantly propor-
tional to death rate for another genotype, and a direct result of
the infection. In this case, the log-rank test is an appropriate
and powerful method of analysis, because it gives equal weightto deaths at all the time points. If a sublethal dose was used
and death rates taper off after a few days, the assumption of pro-
portional hazards is no longer true, i.e. ratios of deaths per time
between groups change with time. In this case, the Gehan–
Breslow–Wilcoxon test, which gives more weight to deaths at
early time points, is more appropriate. If survival curves cross,
neither test is applicable [88].
It should be noted that survival to a given infectious agent is not
comparable between different wild-type backgrounds (Fig. 2A)
with differences reaching statistical signiﬁcance. It goes without
saying that correctly matching the wild-type background to
analysed genotypes and testing different backgrounds is crucial
to survival analysis.
4.3. Bacterial persistence
In order to assess the efﬁciency of an immune response, bacte-
rial clearance can be scored by estimating persistent bacteria with-
in the host. Several more or less quantitative methods are
available. First, the presence or absence of ﬂuorescently labelled
bacteria can be qualitatively assessed by visual inspection under
a ﬂuorescence dissecting microscope. If bacteria are proliferating,
systemic infection results in a completely labelled individual. Local
retention or proliferation of ﬂuorescently labelled bacteria in the
gut can be easily seen through the abdominal cuticle (Fig. 1B). In
our hands, GFP-labelled Ecc15 disappears almost completely from
infected guts within 6–12 h post-ingestion (Fig. 1B and C).
A second method consists in counting colony-forming units per
ﬂy or per tissue at given times after infection. For systemic infec-
tion, we usually encounter considerable variability in CFU per ﬂy
when ﬂies are infected by needle pricking, because of slight varia-
tion in the infectious dose between individuals. This precludes
detection of subtle differences in clearance rates between geno-
types. A better approach is therefore to inject an exactly reproduc-
ible infectious dose by glass capillary and Nanoject™. To count
CFUs, ﬂies are mashed in sterile LB, either manually with a pipette
tip or mechanically in a cell lyser and glass-bead ﬁlled tubes. The
supernatant is then serially diluted in 96-well plates to reach at
least 4 sequential countable dilutions when plated. Dilutions are
plated on LB-agar with selective antibiotic (if applicable) as 3 ll
spots, left to dry for a few minutes and incubated until colonies
are visible (Fig. 2B). A quick and reliable way of counting colonies
is by automated image analysis (Fig. 2C).
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microbial contamination on the ﬂy’s appendages. To eliminate sur-
face bacteria as much as possible, individuals are dipped in 70%
ethanol 5 s, then rinsed in sterile water or PBS and dried by touch-
ing a tissue paper before collecting. This method however has
limitations, because not all ﬂies may be surface-sterilized, and be-
cause ethanol can ﬂood the extremities of the digestive tract and
kill bacteria in the crop or anal pouch.
A third method is PCR-based quantiﬁcation of bacterial genes
on ﬂy extracts (see [89] for Spiroplasma and [26] for M. marinum).4.4. Transcriptional activation, mRNA quantiﬁcation
A straightforward way of assessing expression of genes inde-
pendently of reporter engineering is quantitative real-time PCR.
Technicalities to consider include numbers of individuals and tis-
sues (as an indication: 10 adults or 15 larvae or 15 fat bodies or
20 intestines), extraction (TriZol and isopropanol precipitation or
spin columns), RNA treatment (DNase digestion or not), kinetics
of gene expression, target and reference genes. It can also be useful
to normalize gene induction to a known entity, for example maxi-
mal induction in a given wild-type strain, in order to make sense of
‘‘fold changes’’ upon a test treatment. A selection of reporter genes
is listed in Table 3.
Some general considerations on gene expression may be worth-
while pointing out: although immune gene induction is normally
robust, many genes display circadian rhythmicity, and measure-
ments might be improved by consistent ﬂy husbandry (12 h
light/dark cycle, controlled temperature) [90,91]. NF-jB signalling
(Toll/Imd) in particular is oscillatory in nature and kinetics rather
than single time points may be more informative for a complete
picture of immune homeostasis [92].
While mRNA quantiﬁcation gives a fairly accurate picture of
which genes are switched on, it does not inform on the actual
efﬁciency of the gene products. Indeed, recent publications from
different areas of infection biology suggest that translation can
be inhibited during infection. Ideally, where antibodies or tagged
gene products are available (for example the Dipt-Dpt-HA con-
struct described in [93]), protein expression should be assessed
in parallel to see whether the kinetics of mRNA induction are









CG1365 Cecropin A1 CecA1
CG12763 Diptericin Dpt
CG14704 Peptidoglycan recognition protein LB PGRP-LB
CG11992 Relish Rel
CG15154 Suppressor of cytokine signaling at 36E Socs36E
CG5963 unpaired 3 upd3
CG7850 puckered puc
CG3131 Dual oxidase Duox
CG31508 Turandot C TotC
CG14027 Turandot M TotM
CG10810 Drosomycin Drs
CG32283 Drosomycin-like 3 Drsl3
CG16844 Immune induced molecule 3 IM3
CG6134 spätzle spz
CG5490 Toll Tl4.5. Reporter lines
Reporter constructs which combine immune-inducible promot-
ers with reporter enzymes or ﬂuorescent proteins provide an alter-
native approach to study gene expression in a spatiotemporal
manner. LacZ and GFP enhancer traps are riddling the genome;
alternatively, Gal4 traps can be coupled to UAS-reporters of choice
to assess gene induction [94]. Below we outline immune-speciﬁc
reporter strains (listed in Table 2) and how to use them for
immune gene quantiﬁcation.
4.5.1. Non-ﬂuorescent markers of immune activation
A historical way of scoring gene expression is by enzymatic
titration of a reporter enzyme (peroxidase, b-galactosidase) driven
by the promoter of the gene of interest. P[lac-Z] insertion strains
are available from stock centres for a vast number of genes, see also
Table 2 for a selection of immune gene-lacZ reporters.
To analyse gene expression by X-gal staining and subsequent
microscopic observation, tissues of interest from P[lac-Z]-express-
ing larvae or adults are dissected in PBS at 4 C and ﬁxed in PBS
with 0.5–1% glutaraldehyde at 4 C. Length of ﬁxation depends
on thickness of tissue (seconds for hemocytes, minutes for intes-
tines or fat bodies).
For X-gal staining the following reagents are used: X-gal
(5-bromo-4-chloro-3-indolyl b-D-galactoside) prepared as a 5%
solution in dimethylformamide and stored at 20 C; staining buf-
fer composed of 10 mM NaH2PO4/Na2HPO4, 150 mM NaCl, 1 mM
MgCl2, 3.5 mM K3FeCN6, 3.5 mM K4FeCN6 and adjusted to pH 7.2
with NaOH. X-gal stock should be added to the staining buffer
shortly before use, at 30 ll/ml buffer. After washing the ﬁxed tis-
sues in PBS (1–3 times depending on thickness), incubate in stain-
ing buffer with X-gal at 37 C or at RT. The length of incubation
depends on the amount of expressed enzyme (from minutes to
overnight). Particular attention should be focused on experimental
pH: constitutively expressed b-galactosidase (midgut) is active at
pH 6.5, while P[lac-Z]-derived b-galactosidase has an optimum at
pH 7.5.
To quantify gene expression by b-galactosidase activity titra-
tion, whole animals (3–5 individuals per genotype) or dissected
tissues (15–20 intestines, 10–15 carcasses) are collected and lysed
in glass-bead ﬁlled screw-cap tubes in buffer Z (60 mM Na2HPO4,
60 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM b-mercap-
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immediately processed as melanization interferes with the assay.
Quantiﬁcation is done in a 96-well format; samples and control
buffer are distributed at 5 ll/well, then 200–250 ll buffer Z with
0.35 mg/ml ortho-Nitrophenyl-b-galactoside (ONPG) is added.
Plates are then incubated in a heated microplate reader (37 C)
and measurements taken every 5–10 min at 420 nm. Usually a
half-hour time-course is sufﬁcient to obtain accurate quantiﬁca-
tion; it is advisable to pre-warm the plate for up to 30 min at
37 C as accumulation of the colour reagent may remain undetect-
able at ﬁrst (check for appearance of faint yellow colour in positive
samples). In parallel, set up a 96-well format protein quantiﬁcation
(Bradford or BCA) using the same sample volume (5 ll).
b-Galactosidase activity is expressed as DOD420=DtðminÞprotein concentration0:0045 (in
enzymatic units per amount of protein).
4.5.2. Fluorescent markers of immune activation
Similarly to lac-Z reporter genes described for enzymatic quan-
tiﬁcation, gene expression can also be assessed using ﬂuorescent
reporter strains, listed in Table 2.
If a simple off/on answer is sufﬁcient, ﬂies can be inspected sim-
ply by eye on a ﬂuorescent stereomicroscope. Systemic and local-
ized immune activation is easily scorable from 4 h onwards using
GFP or mCherry ﬂuorescence in whole animals, as illustrated in
Fig. 1B and C. Microscopic analysis of live or ﬁxed and stained im-
mune responsive tissues (for example, hemocytes, tracheae, intes-
tines, fat body) can give a more detailed insight into whether the
response is restricted to speciﬁc cells within a tissue. This is partic-
ularly informative when analysing mosaics as it allows comparing
immune activation of wild-type versus KO cells in a same tissue
exposed to identical levels of infection.
4.6. Melanisation read-outs
Melanisation takes place in the hemolymph compartment and
results in the synthesis of an insoluble black pigment called mela-
nin as well as oxidative by-products, which are bactericidal
[95,96]. During the melanisation reaction, sequential enzymatic
cleavage of secreted serine proteases results in the cleavage of
the pro-phenoloxidase PPO into its enzymatically active form PO.
Once activated PO catalyses the oxidation of phenols into quinones
which subsequently polymerize into melanin. The section below
describes the most common assays used to monitor PO.
4.6.1. Collection of hemolymph
Collection of cell-free hemolymph is the ﬁrst step to any exper-
iments attempting to quantify PO activity. Since pro-phenoloxidas-
es are secreted by crystal cells (see Section 4.6.5), a cell type highly
sensitive to mechanical disruption, great care must be taken to
avoid collecting cells along with the hemolymph.
The easiest and most efﬁcient way of collection is by gentle cen-
trifugation of intact larvae. 15–20 individuals are placed on a
10 lM ﬁlter spin column, covered with 4 mm glass beads and cen-
trifuged for 20 min at 4 C, 10 K rpm in a microcentrifuge. The
weight of the beads is generally sufﬁcient to extract hemolymph
during the run, but animals can be pricked with a needle prior to
centrifugation in order to optimize recovery. The ﬁlter column en-
sures that most cell debris is retained during centrifugation.
A more accurate but also more time-consuming method is
hemolymph collection with a pulled glass capillary mounted on a
Nanoject™ apparatus.
Independently of collection technique, the resulting hemo-
lymph samples need to be kept on ice throughout the collection
process and supplied with a concentrated protease inhibitor solu-
tion (for example Roche cOmplete™ Protease Inhibitor CocktailTablets) to avoid any spontaneous proteolytic activation of PO.
Hemolymph protein concentration can be determined by any con-
ventional protein quantiﬁcation method.
Ideal collection times after wounding are 30 min for larvae and
4 h for adults.
4.6.2. DOPA assay
The DOPA test is a quantitative colorimetric assay frequently
used to monitor PO activity of hemolymph samples. The assay is
based on the conversion by PO of the substrate L-DOPA (L-3,4-dihy-
droxyphenylalanine) into a red pigment called dopachrome and
the measurement of its absorbance at 492 nm. Coloration intensity
is dependent on the initial amount of activated PO in the reaction.
In detail, spectrophotometer cuvettes are ﬁlled with 5–25 lg of
hemolymph protein in a total volume of 200 ll 5 mM CaCl2
solution (containing protease inhibitors, see Section 4.6.1). After
addition of 800 ll L-DOPA solution (20 mM in phosphate buffer ad-
justed to pH 6.6, freshly prepared and protected from light) sam-
ples are incubated at 29 C in the dark. After 30 min the optical
density at 492 nm is measured for each sample (a microplate read-
er can also be used in case of numerous samples) against an
L-DOPA control containing no hemolymph.
Note that because proteases inhibitors were added immediately
after hemolymph collection, the values reﬂect the actual in vivo PO
activity at the time of collection. To measure total PO and PPO
activities, protease inhibitors should be replaced by chymotrypsin
which facilitates the cleavage of PPO into PO. Black cells (Bc) and
PPO1D, PPO2D mutant ﬂies that lack hemolymph PO activity can
be used a negative control for the reaction (see Table 2 for PO-deﬁ-
cient mutants).
4.6.3. PPO cleavage assay
As a complement to the PO assay, a Western Blot using antibod-
ies against Drosophila PO1 and PO2 can be performed on larval or
adult hemolymph samples [97,131]. By this method, both the naïve
PPO (75 kDa) and the mature form of PO (70 kDa), resulting from
PO activation upon proteolytic cleavage by the upstream serine
protease Hayan, can be detected. To enhance the efﬁciency of PO
cleavage, ﬂies can be infected with a mixture of Gram-positive
and Gram-negative bacteria.
4.6.4. Optical read-outs
A very easy but non-quantitative way to monitor the melanisa-
tion reaction in adults consists in pricking ﬂies in the thorax with a
needle as for systemic infections. The blackening of the wounded
area due to melanin deposition can be observed already 30 min
post injury (Fig. 3). To image the size and the intensity of the mel-
anisation on the wounded thorax, pictures can be taken using a
camera attached to a microscope 4 hours post wounding. Note that
the wounding reaction differs according to the bacterial strains; L.
monocytogenesis and S. aureus tend to induce larger melanization
spots [98].
In larvae, the melanisation reaction can be observed in larvae
after pricking with a thin needle usually on posterior side [34].
5 min after injury, synthesis of melanin on the surface of the cuticle
is already visible. Pictures of the melanisation can be taken 30 min
post injury. It is important to keep in mind that the melanisation
reaction can vary considerably between animals. In order to have
a clear representation of the melanisation reaction in wounded
specimen it is essential to repeat the experiment several times
and to take a large number of pictures that illustrates the melan-
ised area. Spn27A1 ﬂies lacking the serpin Spn27A negative regula-
tor show a precocious and uncontrolled melanisation reaction even
in absence of injury. PPO1D, PPO2D or Bc mutant ﬂies that lack
hemolymph PO activity can be used as a negative control of the
reaction (see Table 2).
Fig. 3. Melanisation spot on larvae, pupae and adults. OregonR individuals were pricked with a sterile needle and pictures of melanised wound sites were taken at 30 min
(larvae) or 3 h (pupae and adults) after injury.
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Crystal cells are specialised larval hemocytes responsible for the
synthesis and the release of PPOs. In larvae, crystal cells can be
visualized using a transgenic strain carrying lz-Gal4, UAS-GFP
which expresses GFP under the control of the crystal cell-speciﬁc
promoter lozenge (see Table 2). Alternatively, spontaneous activa-
tion of PPO in crystal cells can be achieved by incubating larvae in
PBS at 65 C for 10 min [99].
4.7. Oxidative burst
Several ROS quantiﬁcation methods have been developed over
recent years. Here we limit ourselves to ROS detection in the gut.
Here we describe one of the more commonly used probes, i.e.
20,70-dichloroﬂuorescein-diacetate (DCFH-DA) that is used to sense
speciﬁcally H2O2 [93,100]. Wemeasured ROS levels in the adult gut
of female ﬂies by the addition of 100 lM DCFH-DA ﬂuorescent dye
(Sigma) to freshly dissected gut tissue. The dissections are done in
the presence of 20 mM NEM (N-ethyl maleimide, Sigma) and the
tissue is preserved in NEM until addition of DCFH-DA dye. The tis-
sue is then incubated in the dye for 30 min and then mounted in
70% Glycerol. Sections of anterior midguts should be imaged. The
DCFH-DA ﬂuorescent signal is analysed using excitation at
488 nm and emission at 529 nm. An important consideration is
growing ﬂies without live yeast as this may inﬂuence basal levels
of ROS in the intestine. For the quantiﬁcation we use pixel values
of signal intensity and take the average signal measured on repre-
sentative ﬁelds of at least 6 guts.
Recently, the group of Won-Jae Lee has employed a novel probe
for measuring ROS in Drosophila intestine [101]. This probe (R19S)
is a rhodamine-based sensor which speciﬁcally reacts with HOCl
and not with other ROS [102]. In the same publication, the group
utilized 100 mM of Amplex UltraRed reagent (Invitrogen) and
0.2 U/ml of horseradish peroxidase (Sigma) reaction buffer to mea-
sure H2O2 in Caenorhabditis elegans. The probe DCFH-DA and Am-
plex UltraRed reagent have been used previously for ﬂuorescence-
based quantitative measurements in human cell culture. For Dro-
sophila a similar quantitative measurement has yet to be reported.
For protocols on how to measure oxidative burst by ﬂuorimetric
indicators coupled to immunohistochemistry, the reader is re-
ferred to the excellent methods developed by the Banerjee lab
(http://www.nature.com/protocolexchange/protocols/414).
4.8. Hemocyte observation
Basic protocols to observe hemocytes were described in [34].
4.9. Phagocytosis assays
The phagocytosis assay described below has been optimised in
our lab from a combination of similar methods [23,103,104]. In thisprotocol, larval hemocytes are collected and mixed with ﬂuores-
cent heat-killed bacteria, incubated and then run on a ﬂow cytom-
eter to measure the fraction of cells phagocytosing and the
intensity of phagocytic uptake. Phagocytosis can be reduced by
injecting beads in the body cavities [105]. Recently, assays to mon-
itor phagosome maturation have been developed [106].
To assay phagocytosis, 2–5 day old 30 female and 15 male ﬂies
are grown in large vials ready-sprinkled with yeast and containing
10 mL 0.05% (w/v) bromophenol blue ﬂy food at 25 C. Cultures are
ﬂipped every morning (24 h) to yield a rearing density of 100–
150 eggs per vial. Collect an excess of wandering L3 larvae with
light blue to white guts. Before dissection, larvae are washed in
H2O to remove food, and re-suspended in PBS but not totally sub-
merged such that they remain oxygenated. Prior to bleeding, larvae
are dried on precision tissues (Kimtech, Kimberly-Clark).
The number of larvae to bleed depends on genotype (see be-
low). Bleeds are collected in 120 ll cold Schneider’s medium (Gib-
co) containing 1 nM phenylthiourea (PTU, Sigma, freshly prepared)
bounded by a hydrophobic ring, drawn using an ImmuEdge pen
(Vector Laboratories Inc., US) on a glass slide. The glass slide is atop
a 9 cm petri plate ﬁlled with ice, used to chill the larvae.
To bleed, chilled larvae are dissected by holding the posterior
with 45-angled tweezers (Inox, No. 5) and with second pair,
pinching posterior cuticle and pulling anteriorly to release hemo-
cytes into the medium. A 100 ll volume of cells is transferred to
an ultra-low attachment 96-well plate (Corning, Costar no. 3474)
and incubated at RT for 10 min. The bacteria are then added:
2  106, 2  107 or 2  108 Alexa-Fluor 488 heat-killed E. coli or
S. aureus (Molecular Probes, for preparation see Section 5.8.3 be-
low) in 10 ll Schneider’s/PTU to each well. The bacteria and hemo-
cytes are mixed by gentle pipetting 7 times. The cells are incubated
at RT for 20 min to enable phagocytosis. Immediately afterwards,
50 ll 0.4% Trypan blue (Sigma, store at RT) is added to quench
the ﬂuorescence of extracellular bioparticles. Trypan blue should
be pre-spun, 10 min, 13,000 rpm to pellet insoluble particles and
kept at RT to avoid precipitation. Immediately run the quenched
sample on a ﬂow cytometer (BD Accuri, US) and measure the mean
ﬂuorescence intensity of the single cell population relative to a
non-ﬂuorescent control (no bacteria added).4.9.1. Calculation of phagocytic index
% of Cells phagocytosing = 100  [number of singlets in ﬂuores-
cence positive gate]/[number of singlets in ﬂuorescence negative
gate].
Phagocytic index, PI = [mean ﬂuorescence intensity of singlet
population in bacteria-added sample]/[mean ﬂuorescence inten-
sity of non-ﬂuorescent, no bacteria added, control].
Typical ﬂow cytometry measurements of hemocyte phagocyto-
sis of AF488-labelled heat killed S. aureus and a calculation of the
phagocytic index are shown in Fig. 4.
Fig. 4. Measurement of the phagocytic index of ex vivo larval hemocytes incubated with AF488-labelled heat killed S. aureus. Shown are the ﬂuorescence intensities of ex vivo
singlet hemocytes from 20 OregonR L3 larvae after incubation with 0, 2  106, 2  107 or 2  108 AF488-labelled heat-killed S. aureus. Each plot represents a single experiment.
Each dot represents a singlet hemocyte. The ﬂuorescence intensity 2 (FL2-A, red) is plotted against the ﬂuorescence intensity 1 (FL1-A, green, AF488 emission). When no
bacteria are added, autoﬂuorescence is measured. Addition of 2  106 AF488 heat-killed S. aureus caused 23.4% of singlet hemocytes to appear in ﬂuorescence gate P3.
Calculations of the phagocytic index, PI, from hFL1ic, the mean FL1 intensity of the no bacteria added control, and hFL1i AF488, the mean FL1 intensity after addition of bacteria
are shown directly below each plot. After addition of 2  108 AF488-S. aureus, phagocytosis was around 50 times higher than after addition of 2  106 AF488-S. aureus.
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Circulating hemocyte number in third instar larvae varies be-
tween genotypes, therefore, to achieve cell-matched assays across
genotypes, it is necessary to adjust the number of larval bleeds be-
tween genotypes. On average, 20 larval bleeds from OregonR yields
5000 singlet hemocytes and w1118 (BL5905) yields 7500 singlet
hemocytes using the above protocol. Therefore, before doing
phagocytosis assays, use the ﬂow cytometer to measure the hemo-
cyte yield per 20 larval bleeds for each genotype and compare to
wild type OregonR. Then use hemocyte yield-adjusted numbers of
larval bleeds to achieve 20 OregonR larval bleed equivalents or
5000 singlet hemocytes for all assays across all genotypes.4.9.3. Preparation of bioparticles
To prepare ﬂuorescent heat-killed Alexa-Fluor conjugated E. coli
or S. aureus (Molecular Probes), 2 mg lyophilized bacteria are dis-
solved in 2 mL sterile PBS and vortexed for 1 min at top speed.
The bacterial particles suspension is further homogenised by pas-
saging 40 times through a 25G  1.500 hypodermic needle (Sterican,
Braun) mounted on a 2 mL syringe. To determine particle number,
dilute a sample serially 10-fold to 1/1000 in PBS, 0.05% Tween-20
and count using a hemocytometer, 40 objective. Typically
1.0–6.0  1010 particles are present per mL. Keep on ice and make
10 ll aliquots, freeze overnight at 80 C and store at 20 C.
While aliquoting, it is extremely important to vortex the bacterial
suspension for 5 s between aliquots.
Before use in a phagocytosis assay, aliquots are diluted to the
desired concentration and vortexed for 30 s after preparation and
for 15 s before each use.4.10. Clotting assay
Several protocols have been developed to monitor clotting in
third instar larvae. This includes various histological methods to
visualize the clot, bead aggregation assays, draw out techniques
to monitor the viscosity of hemolymph. For details see [107] as
well as a movie of a drawout of a hemolymph sample from fondue
mutant larvae http://booksite.elsevier.com/9780123739766/.References
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